BIO
BIO price today and market data
BIO price prediction & outlook
BIO is the token of Bio Protocol, the launchpad and curation layer for decentralized science, and the version on this page is its Solana deployment: a bridged slice of a token whose home is Ethereum and whose global market cap was about $67 million at capture against the $5.5 million Solana float Phantom counts. It launched on January 3, 2025 at its all-time high of $0.889, fell 96% to $0.0158 by March 2026, and had roughly doubled from that low to about $0.031 at capture, up 23% on the week. This is not financial advice.
What actually moves the BIO price
- The DeSci narrative, on and off
- BIO's price is a bet on decentralized science as a sector. The 2026 rebound came in bursts, up 96% in April, 54% in a day in May, 19% in mid-September on "fresh trader interest," each tied to attention on the sector rather than to a product release (Google News). Meanwhile the capital actually committed shrank: Ethereum-side value locked in Bio's contracts fell from about $13.7 million in October 2025 to $3.8 million at capture (DefiLlama).
- Unlocks now flowing
- Of the 3.32 billion total supply, 21.2% belongs to the core team, 13.6% to investors, and 4.2% to advisors, all behind a one-year cliff from the January 2025 launch that has already passed, with linear vesting over four to six years now releasing tokens into a market far below the launch price (Bio docs). About 2.15 billion tokens circulate globally; the rest is scheduled supply.
- The launchpad's throughput
- Bio V2 launches new BioDAO and project tokens at fixed prices, distributes a share to BIO stakers, and unlocks funding once a token holds a valuation milestone for two weeks, so demand for BIO tracks the pipeline of science projects launching through it (Bio docs). More launches mean more staking; a thin pipeline means the token is just a sector proxy.
- Exchange flow, not Solana flow
- Global daily volume ran near $13.9 million, most of it on Binance, Coinbase, OKX, and Upbit; the Solana side had one Raydium pool holding about $437,000 and a day's volume near $100,000 (CoinGecko). Price is set on the exchanges; the Solana pool follows, with more slippage.
- One Solana wallet at 43%
- An unidentified address holds about 43% of the Solana-side supply and the top five about 71%, one of them the Raydium pool itself (RugCheck). For the global token that is a footnote; for anyone trading on Solana it is the local order book.
What would it take for BIO to reach $X?
BIO's supply is global, so a price target maps to its global market cap on roughly 2.15 billion circulating tokens, not to the Solana float shown on this page. The multiples below are computed from the global market cap at capture.
- $0.05~$10M cap2.1x
- $0.10~$20M cap4.2x
- $0.25~$51M cap11x
Can BIO reach $0.10?
A price of $0.10 on roughly 2.15 billion circulating tokens implies a global market cap near $215 million, about three times the level at capture and still a ninth of the January 2025 launch price, with far more supply unlocked than existed then. That would take the DeSci sector attracting capital rather than just headlines, Bio's launchpad producing projects people want to stake for, and the team and investor vesting being absorbed without a slide. These are conditions, not predictions, and this is not financial advice.
To evaluate any BIO target: multiply it by roughly 2.15 billion circulating tokens, then by 3.32 billion for the fully diluted figure, compare both to the global market cap on CoinGecko rather than the Solana float on this page, and ask whether a sector whose locked capital fell by two thirds in a year supports it. If it doesn't, the prediction doesn't hold.
How to buy BIO Protocol (BIO) in Phantom
Buying BIO takes a few minutes once your Phantom wallet holds SOL. BIO is listed on Binance, Coinbase, OKX, and Upbit, so you can also buy it there and withdraw to Phantom on Solana or Ethereum; on Solana it trades in one meaningful Raydium pool, which is where Phantom's swap will route.
- Install Phantom and secure your walletDownload Phantom as a mobile app (iOS or Android) or browser extension and create or import a wallet. Write your Secret Recovery Phrase on paper and store it offline; anyone who obtains it controls every asset in the wallet, and Phantom will never ask for it.
- Fund your wallet with SOLSOL pays the network fee, which runs fractions of a cent, and is the asset the Solana BIO pool is quoted in. Buy SOL inside Phantom with a card or bank transfer, or send it from an exchange, and keep a small balance in reserve for future transactions.
- Paste the mint address, not the nameIn the Swap tab, paste the full mint address as the receive token and confirm it reads BIO on Solana with a holder count in the thousands. A different Solana mint named "bioDAOs" and a pump.fun token called "Link In Bio" both use the BIO ticker, and neither is this token.
- Mind the pool, then confirmThe Raydium BIO/SOL pool held about $437,000 at capture, so orders of a few thousand dollars carry real price impact and larger ones are cheaper on an exchange or on Ethereum. Check the quote against the price on this page, review the estimated output, confirm, and BIO lands in your wallet once Solana confirms.
Always verify the mint address
The legitimate Solana mint address is the one shown on this page; the Ethereum contract is 0xcb1592591996765ec0efc1f92599a19767ee5ffa. Cross-reference either against the CoinGecko listing or Solscan rather than search results or social posts. The official channels are bio.xyz, docs.bio.xyz, and the bridge at bridge.bio.xyz; Bio will never DM you about an airdrop or ask for your Secret Recovery Phrase. If the address does not match exactly, stop.
What buying BIO actually costs
Solana network fees are a fraction of a cent, so on a swap the real costs are the pool's fee and price impact, which is larger here than for most tokens of BIO's size because the Solana pool is small. Holding BIO in Phantom earns nothing by itself; staking it for veBIO on Bio's own platform grants governance rights and allocation in new BioDAO token launches, and moving tokens between Solana and Ethereum goes through Bio's Wormhole-based bridge with its own fees.
Phantom (self-custody) | Centralized exchange | |
|---|---|---|
Who holds your keys | You | The exchange |
Who can freeze funds | Nobody | The exchange can |
Buy path for BIO | Direct in-wallet swap on Solana or Ethereum | Listed on Binance, Coinbase, OKX, Upbit, and others |
What is BIO?
BIO Protocol (BIO) is, as this page's About text says, "Your Gateway to DeSci": a curation and liquidity protocol for decentralized science, built by the team that created Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized longevity-research community (CoinGecko). Its launchpad funds and lists BioDAOs, vertical communities that pool capital for research in fields such as longevity, and in its V2 form launches their tokens at fixed valuations, hands a share to BIO stakers, and releases funding once a token holds a milestone for two weeks; a separate BioAgents line wraps research programs in AI agents (Bio docs). BIO's utility is staking for veBIO, which carries governance and launch access, serving as the pairing asset for ecosystem tokens, and paying for services. The token is Ethereum-native, with the same supply deployed on Base and BNB Chain and bridged to Solana through Wormhole's Native Token Transfers framework on January 9, 2025, six days after launch, which is why the Solana mint is a Token-2022 token whose mint authority is a bridge program address and why this page's supply and market cap describe only the roughly 198 million tokens on Solana (RugCheck).
The token's history is a launch-day peak and a long search for a floor. Binance Labs invested in November 2024, BIO listed through Binance Launchpool on January 3, 2025 and set its all-time high of $0.889 that day, then fell for fourteen months to an all-time low of $0.0158 on March 29, 2026, a 98% drop; a $6.9 million round led by Arthur Hayes's Maelstrom Fund in September 2025 for an AI-native science platform arrived in the middle of the slide (CoinGecko, Google News). The 2026 rebound roughly doubled the price to about $0.031 at capture, still 96% below launch and 78% below a year earlier, for a global market cap near $67 million, rank 396, on about 2.15 billion of 3.32 billion tokens. Value locked in Bio's Ethereum contracts fell from $13.7 million to $3.8 million over the same year (DefiLlama). On Solana, one Raydium pool holds about $437,000, an unidentified wallet holds 43% of the local supply, about 9,400 wallets hold the token, and the global token trades on Binance, Coinbase, OKX, and Upbit. Among DeSci tokens BIO is one of the largest, roughly ten times VitaDAO's VITA and about the size of ResearchCoin.
Is BIO safe?
For a bridged sector token from a real team with a hard chart, safety comes down to three checks and one mindset.
- The bridge
- The Solana mint's authority is a Wormhole NTT program, not a renounced key, because bridged supply must be minted and burned as tokens cross; freeze authority is null. The token's Solana existence depends on that bridge staying secure, and supply is "uncapped by governance" by design (Bio docs).
- Dilution
- The team, investor, and advisor cliffs passed in January 2026 and vesting now runs for years. That is documented, scheduled selling pressure on a token already down 96%.
- The Solana order book
- One pool, one wallet at 43%, and a fraction of a percent of global liquidity. Trade the Solana version knowing the price is made elsewhere and can gap locally.
The mindset: BIO is a bet on decentralized science as an investable category, with the Solana token as a convenient but thin way to hold it. Size it as a small-cap sector bet, watch launches and locked capital rather than price headlines, verify the mint every time, and never share your Secret Recovery Phrase.
BIO FAQ
The market capitalization of BIO is $4.8M as of Nov 1, 2026.
Market capitalization is calculated by multiplying the current price of BIO by its circulating supply. It reflects the overall value of the token in the market and helps gauge its relative size compared to other cryptocurrencies.
The daily trading volume of BIO is $164K as of Nov 1, 2026.
Trading volume can fluctuate based on market conditions, investor activity, and overall demand for BIO.
The total supply of BIO is 203.03M.
The circulating supply, which represents the number of BIO currently available in the market, is 203.03M as of Nov 1, 2026.
BIO can be bought and traded on a variety of cryptocurrency platforms, including Phantom!
BIO is the token of Bio Protocol, a launchpad and curation layer for decentralized science built by the team behind Molecule and VitaDAO. It funds and lists BioDAOs, research communities that raise and govern capital on-chain, and holders stake BIO for veBIO to vote and to receive allocations in new launches. The token is Ethereum-native with a 3.32 billion supply, about 2.15 billion circulating globally, and the Solana version on this page is a Wormhole-bridged deployment of about 198 million tokens.
The project is real, backed by Binance Labs and a Maelstrom-led round, listed on Binance, Coinbase, OKX, and Upbit, and documented at docs.bio.xyz. The risks are a price 96% below its January 2025 launch, team and investor vesting that began in January 2026 and runs for years, capital locked in the protocol falling by two thirds in a year, and on Solana specifically a single pool of about $437,000 with one wallet holding 43% of the local supply. Impostor tokens use the BIO ticker on Solana. Only use funds you can afford to lose. This is not financial advice.
Download Phantom as a mobile app or browser extension and fund it with SOL. Open the Swap tab, paste the mint address shown on this page as the token to receive instead of searching by name, since unrelated Solana tokens use the BIO ticker, and confirm the holder count is in the thousands. The Raydium pool is small, so review price impact, then confirm; for larger orders an exchange or the Ethereum version is cheaper.
Yes. Every Solana transaction, including the swap into BIO, is paid in SOL, and the Solana BIO pool is quoted in SOL. Phantom needs a small SOL balance to cover network fees, which are a fraction of a cent, so a few dollars covers many trades. If you buy the Ethereum version instead, you need ETH for gas on that chain.
The team that built Molecule, the biomedicine tokenization platform, and helped create VitaDAO, per CoinGecko's description of the project; bio.xyz itself names no individuals on its site. Binance Labs invested in November 2024, the token launched through Binance Launchpool on January 3, 2025, and a $6.9 million round led by Arthur Hayes's Maelstrom Fund followed in September 2025. Molecule holds a 5% allocation for transferring intellectual property and stewardship to the protocol.
The Solana version is a bridged deployment of a token whose global supply lives mainly on Ethereum. This page counts only the Solana side, about 198 million bridged tokens of which roughly 176 million are held outside the bridge, worth about $5.5 million at capture, while BIO's global market cap was about $67 million on roughly 2.15 billion circulating tokens. The price is the same everywhere; the supply on each chain is a matter of how many tokens users have bridged.
A price of $0.10 on roughly 2.15 billion circulating tokens implies a global market cap near $215 million, about three times the level at capture in September 2026 and still a ninth of the January 2025 all-time high of $0.889, with far more supply unlocked than at launch. It would take decentralized science attracting real capital, Bio's launchpad producing projects worth staking for, and the market absorbing team and investor vesting. This is not a prediction or financial advice.
Pricing information is provided for informational purposes only and is not financial advice. Market data is provided by third parties and Phantom makes no representation as to the accuracy of the information.
Buy BIO with the Mobile App
Trade from your desktop browser
Trending Tokens
Pricing information is provided for informational purposes only and is not financial advice. Market data is provided by third parties and Phantom makes no representation as to the accuracy of the information.